JRCT ID: jRCT2080224524
Registered date:16/01/2019
-
Basic Information
| Recruitment status | completed |
|---|---|
| Health condition(s) or Problem(s) studied | |
| Date of first enrollment | 07/12/2018 |
| Target sample size | 24 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | investigational material(s) Generic name etc : - INN of investigational material : - Therapeutic category code : 249 Other hormone preparations (including antihormone preparations) Dosage and Administration for Investigational material : - control material(s) Generic name etc : - INN of investigational material : - Therapeutic category code : 249 Other hormone preparations (including antihormone preparations) Dosage and Administration for Investigational material : - |
Outcome(s)
| Primary Outcome | pharmacokinetics |
|---|---|
| Secondary Outcome | safety pharmacokinetics pharmacodynamics - |
Key inclusion & exclusion criteria
| Age minimum | >= 20age old |
|---|---|
| Age maximum | <= 64age old |
| Gender | Both |
| Include criteria | |
| Exclude criteria |
Related Information
| Primary Sponsor | Novo Nordisk Pharma Ltd. |
|---|---|
| Secondary Sponsor | - |
| Source(s) of Monetary Support | - |
| Secondary ID(s) | NCT03766854,JapicCTI-194591 |
Contact
| Public contact | |
| Name | |
| Address | Meiji Yasuda Seimei Bldg., 2-1-1, Marunouchi, Chiyoda-ku, Tokyo |
| Telephone | - |
| - | |
| Affiliation | Novo Nordisk Pharma Ltd. |
| Scientific contact | |
| Name | |
| Address | Meiji Yasuda Seimei Bldg., 2-1-1, Marunouchi, Chiyoda-ku, Tokyo |
| Telephone | - |
| - | |
| Affiliation | Novo Nordisk Pharma Ltd. |